The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
D000284:Administration, Oral; D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects; D003517:Cyclopentanes / Q000008:administration & dosage / Q000494:pharmacology; D004285:Dogs; D005342:Fibrinolysis / Q000187:drug effects*; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D007267:Injections; D008297:Male; D010958:Plasminogen / Q000378:metabolism; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011758:Pyrroles / Q000008:administration & dosage / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors
D003517:Cyclopentanes; D007004:Hypoglycemic Agents; D011758:Pyrroles; D013453:Sulfonylurea Compounds; D010958:Plasminogen